WALTHAM, MA--(Marketwired - February 05, 2015) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced its agreement to participate in CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) archiving of ebooks. CLOCKSS is a community-governed archive committed to open access.
As a not-for-profit venture between academic publishers and research libraries, CLOCKSS is building a sustainable, geographically distributed archive. This ensures the long-term survival of Web-based scholarly publications, such as Elsevier science and technology ebooks, for the benefit of the greater global research community.
"We are committed to providing access to quality research content in perpetuity," said Alicia Wise, Director of Access and Policy, Elsevier. "It's crucial that we work with the librarians and publishers in the CLOCKSS community who share our commitment. The CLOCKSS technology is one of the many reasons it makes such a desirable partner. Just recently, the technology they use to archive ebooks received the highest score ever given in the Technologies, Technical Infrastructure, and Security category in a TRAC audit."
"We are pleased that Elsevier is expanding its preservation activities with CLOCKSS to include its ebooks. Elsevier has been a longstanding supporter and an active member of our board," said Randy Kiefer, Executive Director, CLOCKSS Archive.
CLOCKSS works with leading scholarly publishers to make their content available for free, under a creative commons license, in the event that they can no longer supply it. Participation in CLOCKSS is one way to make sure that, no matter what happens in the publishing market, scholarly research will always remain available to scholars.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey -- and publishes over 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are (EURONEXT AMSTERDAM: REN) (LSE: REL) (NYSE: RUK) (NYSE: ENL).